ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases
ImageneBio has raised $30.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
ImageneBio's investors include Highlight Capital, Blue Owl, OrbiMed, Foresite Capital, RTW Investments.
ImageneBio is headquartered in San Diego, United States.
ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases
ImageneBio is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImageneBio — Funding & Investors." VCBacked, April 13, 2026, https://www.vcbacked.co/company/imagenebio. Accessed July 20, 2026.
VCBacked. (2026). ImageneBio — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/imagenebio
{{cite web |title=ImageneBio — Funding & Investors |url=https://www.vcbacked.co/company/imagenebio |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated